Project Grant HT94252310663
Award Date
7/15/23
Completion Date
7/14/27
Dollars Obligated
$7.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30332, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $1,024,635 Project Grant to Corvion, Inc. to develop a Totally Implanted Left Ventricular Assist Device (TI-LVAD). The TI-LVAD aims to provide an improved treatment option for the over 6.5 million Americans suffering from heart failure, by reducing complications and enhancing patient quality of life compared to current LVAD devices. The key enabling technology is a...
This $8.7 million project grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports the development of patient care technologies for permanent ambulatory artificial lung support from May 2022 to April 2026. Carnegie Mellon University is the primary awardee and will develop technologies to transition a pulmonary assist system to long-term support of chronic lung disease patients. Vanderbilt University Medical...
This federal Project Grant award, valued at $363,160.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant funds the University of Texas Southwestern Medical Center, also known as Southwestern Medical School, to conduct research on the development of bioresorbable heart valves. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by...
This Project Grant award of $260,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Palo Alto Veterans Institute for Research (PAVIR) to study the application of electrical current for promoting lymphatic regeneration. The research will be conducted by PAVIR in collaboration with Stanford University as a sub-recipient. The project seeks to experimentally investigate the electrokinetics of collagen matrix materials and...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $502,294 to Georgia Tech Research Corp to develop engineered biomaterials for promoting lymphatic regeneration in lymphedema. The key products and services to be delivered include: Evaluating lymphangiogenic hydrogels and their capacity to induce lymphangiogenesis and facilitate engraftment of transplanted lymph nodes into the host lymphatic vasculature. Assessing...
This $653,317 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel graft-localized drug delivery platform at Wake Forest University Health Sciences (WFUHS). The funding will be used to conduct research aimed at attenuating innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation over a 2-year period from September 2024 to September 2026. WFUHS, a leading...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This federal Project Grant award, valued at $3,618,191.00 and issued on July 1, 2024, is funded by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The award supports the development of a portable hemodialysis device to facilitate home use and field implementation. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will lead the research and development efforts. This includes optimizing a...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $818,337 to Vascular Perfusion Solutions Inc. to conduct research on "Extended Limb Stasis in the Encore Tissue Preservation Device". The award period runs from August 15, 2025 to August 14, 2027. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical...
This federal Project Grant award of $325,142, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, which has a performance period from September 1, 2025 to August 31, 2028, is being provided to Onward Medical Inc., a for-profit organization located in Boston, MA. The goal of this...